133 related articles for article (PubMed ID: 30412404)
1. Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity.
Messore A; Madia VN; Pescatori L; Saccoliti F; Tudino V; De Leo A; Bortolami M; De Vita D; Scipione L; Pepi F; Costi R; Rivara S; Scalvini L; Mor M; Ferrara FF; Pavoni E; Roscilli G; Cassinelli G; Milazzo FM; Battistuzzi G; Di Santo R; Giannini G
J Med Chem; 2018 Dec; 61(23):10834-10859. PubMed ID: 30412404
[TBL] [Abstract][Full Text] [Related]
2. Novel Benzazole Derivatives Endowed with Potent Antiheparanase Activity.
Madia VN; Messore A; Pescatori L; Saccoliti F; Tudino V; De Leo A; Bortolami M; Scipione L; Costi R; Rivara S; Scalvini L; Mor M; Ferrara FF; Pavoni E; Roscilli G; Cassinelli G; Milazzo FM; Battistuzzi G; Di Santo R; Giannini G
J Med Chem; 2018 Aug; 61(15):6918-6936. PubMed ID: 30010344
[TBL] [Abstract][Full Text] [Related]
3. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
[TBL] [Abstract][Full Text] [Related]
4. Development of heparanase inhibitors for anti-cancer therapy.
Miao HQ; Liu H; Navarro E; Kussie P; Zhu Z
Curr Med Chem; 2006; 13(18):2101-11. PubMed ID: 16918340
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.
Jia L; Ma S
Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase.
Pala D; Rivara S; Mor M; Milazzo FM; Roscilli G; Pavoni E; Giannini G
Glycobiology; 2016 Jun; 26(6):640-54. PubMed ID: 26762172
[TBL] [Abstract][Full Text] [Related]
7. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
Zhou Z; Bates M; Madura JD
Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
[TBL] [Abstract][Full Text] [Related]
8. Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors.
Rondanin R; Fochi S; Baruchello R; Bernardi T; Oliva P; Semeraro F; Simoni D; Giannini G
Bioorg Med Chem Lett; 2017 Sep; 27(18):4421-4425. PubMed ID: 28811133
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
10. 2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors.
Courtney SM; Hay PA; Buck RT; Colville CS; Porter DW; Scopes DI; Pollard FC; Page MJ; Bennett JM; Hircock ML; McKenzie EA; Stubberfield CR; Turner PR
Bioorg Med Chem Lett; 2004 Jun; 14(12):3269-73. PubMed ID: 15149688
[TBL] [Abstract][Full Text] [Related]
11. 1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors.
Pan W; Miao HQ; Xu YJ; Navarro EC; Tonra JR; Corcoran E; Lahiji A; Kussie P; Kiselyov AS; Wong WC; Liu H
Bioorg Med Chem Lett; 2006 Jan; 16(2):409-12. PubMed ID: 16246560
[TBL] [Abstract][Full Text] [Related]
12. N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors.
Xu YJ; Miao HQ; Pan W; Navarro EC; Tonra JR; Mitelman S; Camara MM; Deevi DS; Kiselyov AS; Kussie P; Wong WC; Liu H
Bioorg Med Chem Lett; 2006 Jan; 16(2):404-8. PubMed ID: 16246551
[TBL] [Abstract][Full Text] [Related]
13. New classes of potent heparanase inhibitors from ligand-based virtual screening.
Pala D; Scalvini L; Elisi GM; Lodola A; Mor M; Spadoni G; Ferrara FF; Pavoni E; Roscilli G; Milazzo FM; Battistuzzi G; Rivara S; Giannini G
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1685-1696. PubMed ID: 32907434
[TBL] [Abstract][Full Text] [Related]
14. 1H NMR spectroscopic studies establish that heparanase is a retaining glycosidase.
Wilson JC; Laloo AE; Singh S; Ferro V
Biochem Biophys Res Commun; 2014 Jan; 443(1):185-8. PubMed ID: 24291708
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase.
Dai X; Yan J; Fu X; Pan Q; Sun D; Xu Y; Wang J; Nie L; Tong L; Shen A; Zheng M; Huang M; Tan M; Liu H; Huang X; Ding J; Geng M
Clin Cancer Res; 2017 Oct; 23(20):6267-6278. PubMed ID: 28710312
[No Abstract] [Full Text] [Related]
16. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
Vlodavsky I; Ilan N; Naggi A; Casu B
Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
[TBL] [Abstract][Full Text] [Related]
17. The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation.
Ferro V; Hammond E; Fairweather JK
Mini Rev Med Chem; 2004 Aug; 4(6):693-702. PubMed ID: 15279603
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues.
Marchetti D; Reiland J; Erwin B; Roy M
Int J Cancer; 2003 Mar; 104(2):167-74. PubMed ID: 12569571
[TBL] [Abstract][Full Text] [Related]
19. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
[TBL] [Abstract][Full Text] [Related]
20. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
